Navigation Links
NHGRI expands effort to revolutionize sequencing technologies

The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced it has awarded grants totaling more than $32 million to advance the development of innovative sequencing technologies intended to reduce the cost of DNA sequencing and expand the use of genomics in biomedical research and health care.

"The efforts are aimed at speeding the rate at which the next generation of sequencing technologies become available in the scientific lab and the medical clinic," said NHGRI Director Francis S. Collins, M.D., Ph.D. "Not only will these technologies substantially reduce the cost of sequencing a genome, but they will provide a quantum leap in the scope and scale of research aimed at uncovering the genomic contributions to common diseases, such as cancer, heart disease and diabetes."

Over the past decade, DNA sequencing costs have fallen more than 50-fold, fueled in large part by tools, technologies and process improvements developed as part of the successful effort to sequence the human genome. However, it still costs about $10 million to sequence 3 billion base pairs ?the amount of DNA found in the genomes of humans and other mammals.

NHGRI's near-term goal is to lower the cost of sequencing a mammalian-sized genome to $100,000, which would enable researchers to sequence the genomes of hundreds or even thousands of people as part of studies to identify genes that contribute to common, complex diseases. Ultimately, NHGRI's vision is to cut the cost of whole-genome sequencing to $1,000 or less, which will enable the sequencing of individual genomes as part of routine medical care. The ability to sequence an individual genome cost-effectively could enable health care professionals to tailor diagnosis, treatment and prevention to each person's unique genetic profile.

The new grants balance NHGRI's sequencing research portfolio by supporting more investigators working on technologies that woul
'"/>

Source:NIH


Page: 1 2 3 4 5

Related biology news :

1. NHGRI targets 12 more organisms for genome sequencing
2. NHGRI Selects 13 More Organisms for Genome Sequencing
3. NHGRI announces new sequencing targets
4. NHGRI announces latest sequencing targets
5. NHGRI aims to make DNA sequencing faster, more cost effective
6. International HapMap consortium expands mapping effort
7. Gene expands malarias invasion options
8. MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools
9. New book expands biological classifications to account for alien life
10. New study expands understanding of the role of RNA editing in gene control
11. NIAID expands capability for influenza research and surveillance

Post Your Comments:
(Date:11/22/2009)... -- A butterfly,s proboscis looks like a straw -- ...s more like a paper towel, according to Konstantin...the tricks of this piece of insect anatomy to make...cells. , Kornev will present his work next week ...l Society,s (APS) Division of Fluid Dynamics will ...
(Date:11/20/2009)...ny scientific and technological frontiers. The Nat...port that totals nearly $4.3 million for the diver...e American Recovery and Reinvestment Act of 2009. ...r investigation of solar phenomena. Philip R. Good...e the capabilities of NJIT,s Big Bear Solar Observ...
(Date:11/20/2009)...of Oklahoma researchers were sequencing the first ...ct. Today, the OU Advanced Center for Genome Tec... to sequence the tomato genome with a $7.5 million...for plant genomics. , "The tomato has tremendou...and crop yields will improve quality of life," sai...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 1Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 2Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 3Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 4Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 5Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 6Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 7Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 8Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 9Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 10Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 11Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 12Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 13Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 14Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 15Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 16Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 17Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 18Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 19Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 20Reportlinker Adds Proteomics 3A Technologies and Global Markets Report 13844 21European Urology September issue features Surgery in Motion article 56200 1GEN reports on expanding NextGen sequencing applications 9789 1GEN reports on expanding NextGen sequencing applications 9789 2
... and sea surface heating from global warming disru...sts predict ?the effect on the ocean food chain in...cording to a new study just published in Nature. ,...phytoplankton could decrease by as much as 20 perc... the loss could hit 50 percent. The study was cond...
...ng-distance race may do serious harm rather than k...ch, according to a cardiologist at UT Southwestern...hletes who drink too much water during a race coul...tremia, a condition marked by a loss in the body,s...ms such as lethargy, disorientation, seizures and ...
...y biophysicist Stuart Lindsay from the Biodesign I...he first reproducible single molecule negative dif...ed a groundbreaking experimental technique that pr...vices based on biochemistry. , The findings were ...iation for the Advancement of Science annual meeti...
Other Biology News:Currents could disrupt ocean food chain 2New design : complete 2Successful Test Of Single Molecule Switch Opens The Door To Biomolecular Electronics 2Successful Test Of Single Molecule Switch Opens The Door To Biomolecular Electronics 3
(Date:11/19/2009)...wswire-FirstCall/ -- Omeros Corporation (Nasdaq: ... for the third quarter ended September 30, 2009. F...os reported a net loss of $3.9 million, or $1.34 p...n, or $2.54 per share, for the same period in 2008...e Company reported a net loss of $15.5 million, or...
(Date:11/19/2009)...ALTHAM, Mass., Nov. 19 Arlington M... that the leading driver of antibiotic selection i... activity against gram-positive and gram-negative ...n cause nosocomial pneumonia, surveyed European ph...s that provide appropriate coverage against common...
(Date:11/19/2009)... is honored by latest award for revolutionary hear...WEB) November 16, 2009 -- Popular Science Magazine...ng aid from InSound Medical a winner of its covete...egory.    Chosen from thousand... the hearing canal for up to four months while pro...
(Date:11/18/2009)...lka-dotted postage stamp that can sniff out poison...rs. , As reported in the Sept. 13 issue of the j... team at the University of Illinois have developed...oxic industrial chemicals (TICs) that is simple, f...s. This sensor array could be useful in detecting...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
...esents Largest Chemically Defined Structure Synthe...hree Step Process to Create Synthetic,Organism, R...t the J. Craig Venter Institute (JCVI) has created...g and assembling the 582,970 base pair,genome of a...ork, published,online today in the journal Science...
...., Jan. 24 ProCure Treatment Centers,Inc (ProCure... Systems, an,Elekta Company, as a preferred provid...BA-equipped proton beam therapy centers. ProCure d...ters in partnership with local,radiation oncologis...eveloping proton beam therapy centers is the,staff...
... Jan. 23 According to a recent College,of Pharmac...er-the-counter,product for minor wound care is sub...RSA, including the virulent strain USA300. Scienti...r-the-counter wound care treatments for,effectiven...A. Breaks in,the skin, such as cuts and scrapes, a...
Other Biology Technology:Venter Institute Scientists Create First Synthetic Bacterial Genome 2Venter Institute Scientists Create First Synthetic Bacterial Genome 3Venter Institute Scientists Create First Synthetic Bacterial Genome 4Venter Institute Scientists Create First Synthetic Bacterial Genome 5Venter Institute Scientists Create First Synthetic Bacterial Genome 6ProCure Selects IMPAC as Provider of Oncology Information Systems 2Researchers Pinpoint Best Treatment to Reduce Deadly USA300, MRSA Staph Infections 2Researchers Pinpoint Best Treatment to Reduce Deadly USA300, MRSA Staph Infections 3
Mouse Anti-CNG Channel Monoclonal Antibody, Unconjugated, Clone CNC 9C1 from ABR-Affinity BioReagents
Anti-IRF7 Polyclonal Antibody, Unconjugated from Invitrogen
Rabbit Anti-Rat Synapsin I, phospho (Ser603) Monoclonal Antibody, Clone PS603 from Invitrogen
Mouse Anti-MMP-20 Monoclonal Antibody, Unconjugated, Clone MMP2/2C1 from ABR-Affinity BioReagents
Biology Products: